7Baggers
 replimune group, inc. securities lawsuit investigation  Claim Depot Wed, 24 Sep 2025 17:46:29 GMT
 repl stock plunges 54% in 3 months after fda rejects skin cancer drug  sharewise.com Wed, 24 Sep 2025 14:26:15 GMT
 Replimune Group (REPL) Receives a Hold from Barclays  The Globe and Mail Wed, 24 Sep 2025 07:00:00 GMT
 REPLIMUNE FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C.  GlobeNewswire Tue, 23 Sep 2025 00:41:45 GMT
 investigation announced for long-term investors in shares  openPR.com Mon, 22 Sep 2025 22:23:38 GMT
 replimune final deadline alert: bragar eagel & squire, p.c.  GlobeNewswire Mon, 22 Sep 2025 14:31:00 GMT
 Opinion | Dr. Prasad, the FDA’s Grim Reaper  The Wall Street Journal Mon, 22 Sep 2025 07:00:00 GMT
 repl deadline tomorrow: rosen, skilled investor counsel,  GlobeNewswire Mon, 22 Sep 2025 02:37:56 GMT
 why replimune stock plummeted by almost 40% today  MSN Sun, 21 Sep 2025 21:36:15 GMT
 repl deadline tomorrow: rosen, skilled investor counsel,  GlobeNewswire Sun, 21 Sep 2025 16:18:05 GMT
 repl investor alert: bronstein, gewirtz & grossman llc  GlobeNewswire Sun, 21 Sep 2025 16:01:08 GMT
 replimune looks to raise $125m through public offering  MSN Sat, 20 Sep 2025 22:47:25 GMT
 Why Replimune Stock Was Tumbling Again Today  MSN Sat, 20 Sep 2025 02:14:49 GMT
 replimune (repl) faces downgrade amid regulatory uncertainty  GuruFocus Fri, 19 Sep 2025 15:56:15 GMT
 jp morgan downgrades replimune group (repl) to underweight | rep  GuruFocus Fri, 19 Sep 2025 12:47:48 GMT
 jpmorgan downgrades replimune group to underweight from neutral  MarketScreener Fri, 19 Sep 2025 11:24:54 GMT
 replimune lacks clear pathway in melanoma after fda meeting  The Pharma Letter Fri, 19 Sep 2025 10:02:34 GMT
 factset, metlife, replimune  TradingView Fri, 19 Sep 2025 07:27:52 GMT
 factset, metlife, replimune group  TradingView Fri, 19 Sep 2025 07:27:52 GMT
 Why Replimune Stock Was Tumbling Again Today  The Motley Fool Fri, 19 Sep 2025 07:00:00 GMT
 Replimune stock downgraded at J.P. Morgan (REPL:NASDAQ)  Seeking Alpha Fri, 19 Sep 2025 07:00:00 GMT
 Pittsburgh Post-Gazette  FinancialContent Fri, 19 Sep 2025 07:00:00 GMT
 replimune alert: bragar eagel & squire, p.c. reminds  GlobeNewswire Fri, 19 Sep 2025 07:00:00 GMT
 replimune stock rating downgraded by jpmorgan on regulatory concerns  Investing.com Fri, 19 Sep 2025 07:00:00 GMT
 replimune stock unchanged as h.c. wainwright maintains neutral rating  Investing.com Fri, 19 Sep 2025 07:00:00 GMT
 replimune (repl) stock dips amid fda meeting and analyst downgra  GuruFocus Fri, 19 Sep 2025 07:00:00 GMT
 replimune group, inc. (nasdaq: repl) shareholder alert  GlobeNewswire Fri, 19 Sep 2025 00:01:41 GMT
 Replimune (REPL) Engages with FDA on Melanoma Treatment Plan  GuruFocus Thu, 18 Sep 2025 15:02:35 GMT
 replimune (repl) evaluates fda feedback on melanoma treatment  GuruFocus Thu, 18 Sep 2025 14:37:30 GMT
 Replimune Stock Plunged 42% Today – Here’s Why  Stocktwits Thu, 18 Sep 2025 07:00:00 GMT
 Replimune Group, Inc. Investors: Please contact the Portnoy  GlobeNewswire Thu, 18 Sep 2025 07:00:00 GMT
 REPLIMUNE GROUP, INC. (NASDAQ: REPL) SHAREHOLDER ALERT  GlobeNewswire Thu, 18 Sep 2025 07:00:00 GMT
 Why Replimune Stock Plummeted by Almost 40% Today  The Motley Fool Thu, 18 Sep 2025 07:00:00 GMT
 BREAKING: Replimune Shares Drop Over 40%; Investors Should  GlobeNewswire Thu, 18 Sep 2025 07:00:00 GMT
 Replimune stock plunges after FDA meeting fails to clear path forward  Investing.com Thu, 18 Sep 2025 07:00:00 GMT
 Replimune Group Completes FDA Meeting on RP1 Application  TipRanks Thu, 18 Sep 2025 07:00:00 GMT
 Melanoma drug developer stock crashes after report from FDA meeting  The Business Journals Thu, 18 Sep 2025 07:00:00 GMT
 Replimune Provides Update Following Type A Meeting with FDA  The Manila Times Thu, 18 Sep 2025 07:00:00 GMT
 replimune (repl) faces setback after fda meeting  GuruFocus Thu, 18 Sep 2025 07:00:00 GMT
 replimune holds fda meeting to discuss melanoma drug rejection  Investing.com Thu, 18 Sep 2025 07:00:00 GMT
 shareholders that lost money on replimune group, inc.  GlobeNewswire Thu, 18 Sep 2025 07:00:00 GMT
 replimune shares fall as regulatory uncertainty looms for melanoma drug  MarketScreener Thu, 18 Sep 2025 07:00:00 GMT
 10 stocks losing big amid market boom  Insider Monkey Thu, 18 Sep 2025 07:00:00 GMT
 replimune says path forward not determined for rp1 in advanced melanoma  MarketScreener Thu, 18 Sep 2025 07:00:00 GMT
 REPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC  GlobeNewswire Wed, 17 Sep 2025 07:00:00 GMT
 published on: 2025-09-17 02:33:58  خودرو بانک Tue, 16 Sep 2025 23:04:09 GMT
 investors suewallst as replimune group, inc. faces securities fraud allegations  Louisiana First News Tue, 16 Sep 2025 21:00:00 GMT
 replimune group, inc. investors: please contact the portnoy  GlobeNewswire Tue, 16 Sep 2025 20:56:54 GMT
 pittsburgh post-gazette  FinancialContent Tue, 16 Sep 2025 07:00:00 GMT
 shareholder alert bernstein liebhard llp announces a  GlobeNewswire Tue, 16 Sep 2025 05:10:07 GMT
 replimune alert: bragar eagel & squire, p.c. reminds  GlobeNewswire Tue, 16 Sep 2025 01:38:01 GMT
 repl deadline: rosen, national investor counsel, encourages  GlobeNewswire Tue, 16 Sep 2025 01:24:00 GMT
 REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. Reminds  GlobeNewswire Mon, 15 Sep 2025 07:00:00 GMT
 REPL DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages  GlobeNewswire Mon, 15 Sep 2025 07:00:00 GMT
 Pittsburgh Post-Gazette  FinancialContent Mon, 15 Sep 2025 07:00:00 GMT
 repl deadline: rosen, nationally regarded investor counsel,  GlobeNewswire Fri, 12 Sep 2025 20:16:43 GMT
 about us  FinancialContent Fri, 12 Sep 2025 20:00:00 GMT
 repl investor alert: bronstein, gewirtz & grossman llc  GlobeNewswire Thu, 11 Sep 2025 16:39:50 GMT
 Analysts Set Replimune Group, Inc. (NASDAQ:REPL) Price Target at $6.50  Defense World Thu, 11 Sep 2025 07:00:00 GMT
 replimune alert: bragar eagel & squire, p.c. reminds  GlobeNewswire Thu, 11 Sep 2025 07:00:00 GMT
 replimune group, inc. class action: the gross law firm  GlobeNewswire Wed, 10 Sep 2025 19:48:28 GMT
 replimune group, inc. investors: please contact the portnoy  GlobeNewswire Tue, 09 Sep 2025 20:41:09 GMT
 replimune stock steady as h.c. wainwright maintains neutral rating  Investing.com Tue, 09 Sep 2025 07:00:00 GMT
 REPLIMUNE GROUP, INC. (NASDAQ: REPL) SHAREHOLDER ALERT  GlobeNewswire Mon, 08 Sep 2025 07:00:00 GMT
 repl 2-week deadline alert: replimune (repl) faces investor  GlobeNewswire Mon, 08 Sep 2025 07:00:00 GMT
 replimune alert: bragar eagel & squire, p.c. announces that  GlobeNewswire Sun, 07 Sep 2025 15:14:29 GMT
 faruqi & faruqi reminds replimune investors of the pending  GlobeNewswire Sun, 07 Sep 2025 07:00:00 GMT
 replimune group, inc. investors: please contact the portnoy  GlobeNewswire Fri, 05 Sep 2025 22:18:45 GMT
 how to contact the daily bulletin  FinancialContent Fri, 05 Sep 2025 19:45:00 GMT
 REPL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages  GlobeNewswire Fri, 05 Sep 2025 07:00:00 GMT
 the gross law firm announces the filing of a securities  GlobeNewswire Thu, 04 Sep 2025 20:01:18 GMT
 repl investor alert: bronstein, gewirtz & grossman llc  GlobeNewswire Thu, 04 Sep 2025 16:06:56 GMT
 replimune alert: bragar eagel & squire, p.c. is  GlobeNewswire Thu, 04 Sep 2025 09:31:11 GMT
 Replimune Group Schedules Crucial FDA Meeting for RP1  TipRanks Thu, 04 Sep 2025 07:00:00 GMT
 replimune group, inc. (nasdaq: repl) shareholder alert  GlobeNewswire Wed, 03 Sep 2025 07:00:29 GMT
 REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. is  GlobeNewswire Wed, 03 Sep 2025 07:00:00 GMT
 Replimune Group Schedules Crucial FDA Meeting for RP1  MSN Wed, 03 Sep 2025 07:00:00 GMT
 replimune group, inc. (nasdaq: repl) shareholder alert  GlobeNewswire Tue, 02 Sep 2025 13:42:29 GMT
 Replimune Prepares for Type A Meeting With FDA on RP1  Dermatology Times Tue, 02 Sep 2025 07:00:00 GMT
 Replimune stock gains on FDA Type A meeting (REPL:NASDAQ)  Seeking Alpha Tue, 02 Sep 2025 07:00:00 GMT
 Silicon Valley  FinancialContent Tue, 02 Sep 2025 07:00:00 GMT
 Replimune Announces Type A Meeting Scheduled with FDA  The Manila Times Tue, 02 Sep 2025 07:00:00 GMT
 trump pressures drugmakers amid cdc turmoil  statnews.com Tue, 02 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 13:54:36  خودرو بانک Tue, 02 Sep 2025 07:00:00 GMT
 rosen, trusted investor counsel, encourages replimune  GlobeNewswire Tue, 02 Sep 2025 02:05:00 GMT

Replimune Group, Inc
(NASDAQ:REPL) 

REPL stock logo

Replimune Group, Inc., a biotechnology company, develops oncolytic immune-gene therapies to treat cancer. It uses its proprietary Immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a...

Founded: 2015
Full Time Employees: 122
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends